These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 9548457
21. Cloning and expression analysis of a novel G-protein-coupled receptor selectively expressed on granulocytes. Yousefi S, Cooper PR, Potter SL, Mueck B, Jarai G. J Leukoc Biol; 2001 Jun; 69(6):1045-52. PubMed ID: 11404393 [Abstract] [Full Text] [Related]
22. Molecular cloning and functional characterization of a novel member of the C-C chemokine family. Hara T, Bacon KB, Cho LC, Yoshimura A, Morikawa Y, Copeland NG, Gilbert DJ, Jenkins NA, Schall TJ, Miyajima A. J Immunol; 1995 Dec 01; 155(11):5352-8. PubMed ID: 7594550 [Abstract] [Full Text] [Related]
23. Hemofiltrate CC chemokines with unique biochemical properties: HCC-1/CCL14a and HCC-2/CCL15. Forssmann U, Mägert HJ, Adermann K, Escher SE, Forssmann WG. J Leukoc Biol; 2001 Sep 01; 70(3):357-66. PubMed ID: 11527984 [Abstract] [Full Text] [Related]
24. High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cells. Parody TR, Stone MJ. Cytokine; 2004 Jul 07; 27(1):38-46. PubMed ID: 15207250 [Abstract] [Full Text] [Related]
25. Characterization of the signal transduction pathway activated in human monocytes and dendritic cells by MPIF-1, a specific ligand for CC chemokine receptor 1. Nardelli B, Tiffany HL, Bong GW, Yourey PA, Morahan DK, Li Y, Murphy PM, Alderson RF. J Immunol; 1999 Jan 01; 162(1):435-44. PubMed ID: 9886417 [Abstract] [Full Text] [Related]
27. Involvement of leukotactin-1, a novel CC chemokine, in human atherosclerosis. Yu R, Kim CS, Kawada T, Kwon TW, Lim TH, Kim YW, Kwon BS. Atherosclerosis; 2004 May 01; 174(1):35-42. PubMed ID: 15135248 [Abstract] [Full Text] [Related]
28. Genomic organization of the CC chemokine mip-3alpha/CCL20/larc/exodus/SCYA20, showing gene structure, splice variants, and chromosome localization. Nelson RT, Boyd J, Gladue RP, Paradis T, Thomas R, Cunningham AC, Lira P, Brissette WH, Hayes L, Hames LM, Neote KS, McColl SR. Genomics; 2001 Apr 01; 73(1):28-37. PubMed ID: 11352563 [Abstract] [Full Text] [Related]
29. Identification of a new mouse beta-chemokine, thymus-derived chemotactic agent 4, with activity on T lymphocytes and mesangial cells. Tanabe S, Lu Z, Luo Y, Quackenbush EJ, Berman MA, Collins-Racie LA, Mi S, Reilly C, Lo D, Jacobs KA, Dorf ME. J Immunol; 1997 Dec 01; 159(11):5671-9. PubMed ID: 9548511 [Abstract] [Full Text] [Related]
30. Effect of leukotactin-1 on the protection in vivo of myeloid progenitor cells against cytotoxic chemotherapeutics. Kim WY, Broxmeyer HE, Han IS, Park DH, Lee KM, Vinay DS, Kwon BS. J Hematother Stem Cell Res; 2003 Feb 01; 12(1):107-13. PubMed ID: 12662441 [Abstract] [Full Text] [Related]
31. Bacterial superantigens induce down-modulation of CC chemokine responsiveness in human monocytes via an alternative chemokine ligand-independent mechanism. Rahimpour R, Mitchell G, Khandaker MH, Kong C, Singh B, Xu L, Ochi A, Feldman RD, Pickering JG, Gill BM, Kelvin DJ. J Immunol; 1999 Feb 15; 162(4):2299-307. PubMed ID: 9973507 [Abstract] [Full Text] [Related]
32. A novel, selective, and orally available antagonist for CC chemokine receptor 3. Morokata T, Suzuki K, Masunaga Y, Taguchi K, Morihira K, Sato I, Fujii M, Takizawa S, Torii Y, Yamamoto N, Kaneko M, Yamada T, Takahashi K, Shimizu Y. J Pharmacol Exp Ther; 2006 Apr 15; 317(1):244-50. PubMed ID: 16339911 [Abstract] [Full Text] [Related]
33. CC chemokine receptors 1 and 3 are differentially regulated by IL-5 during maturation of eosinophilic HL-60 cells. Tiffany HL, Alkhatib G, Combadiere C, Berger EA, Murphy PM. J Immunol; 1998 Feb 01; 160(3):1385-92. PubMed ID: 9570558 [Abstract] [Full Text] [Related]
34. Leukotactin-1/CCL15 induces cell migration and differentiation of human eosinophilic leukemia EoL-1 cells through PKCdelta activation. Lee JS, Kim IS. Mol Biol Rep; 2010 Jun 01; 37(5):2149-56. PubMed ID: 19669929 [Abstract] [Full Text] [Related]
35. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice. Wareing MD, Lyon AB, Lu B, Gerard C, Sarawar SR. J Leukoc Biol; 2004 Oct 01; 76(4):886-95. PubMed ID: 15240757 [Abstract] [Full Text] [Related]
36. Analysis of eosinophils and myeloid progenitor responses to modified forms of MPIF-2. Grzegorzewski KJ, Yao XT, Kreider B, Olsen HS, Morris TS, Zhang L, Sanyal I, Nardelli B, Zukauskas D, Brewer L, Bong GW, Kim Y, Garotta G, Salcedo TW. Cytokine; 2001 Feb 21; 13(4):209-19. PubMed ID: 11237428 [Abstract] [Full Text] [Related]
37. Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours. Scotton C, Milliken D, Wilson J, Raju S, Balkwill F. Br J Cancer; 2001 Sep 14; 85(6):891-7. PubMed ID: 11556842 [Abstract] [Full Text] [Related]
38. Isolation and characterization of Exodus-2, a novel C-C chemokine with a unique 37-amino acid carboxyl-terminal extension. Hromas R, Kim CH, Klemsz M, Krathwohl M, Fife K, Cooper S, Schnizlein-Bick C, Broxmeyer HE. J Immunol; 1997 Sep 15; 159(6):2554-8. PubMed ID: 9300671 [Abstract] [Full Text] [Related]
39. Regulation of human LZIP expression by NF-kappaB and its involvement in monocyte cell migration induced by Lkn-1. Jang SW, Kim YS, Kim YR, Sung HJ, Ko J. J Biol Chem; 2007 Apr 13; 282(15):11092-100. PubMed ID: 17296613 [Abstract] [Full Text] [Related]